Top

Journal of Neurology

Published in:

01-07-2010 | Medical Progress in the Journal of Neurology

Parkinson’s disease and 2009: recent advances

Authors: David P. Breen, Roger A. Barker

Published in: Journal of Neurology | Issue 7/2010

Abstract

This short review summarises the PD related research published in the Journal of Neurology in 2009.

Williams-Gray CH, Goris A, Saiki M, Foltynie T, Compston DAS, Sawcer SJ, Barker RA (2009) Apolipoprotein E genotype as a risk factor for susceptibility to and dementia in Parkinson’s disease. J Neurol 256:493–498CrossRefPubMed

Zschiedrich K, Konig IR, Bruggemann N, Kock N, Kasten M, Leenders KL, Kostic V, Vieregge P, Ziegler A, Klein C, Lohmann K (2009) MDR1 variants and risk of Parkinson disease: association with pesticide exposure? J Neurol 256:115–120CrossRefPubMed

Hassin-Baer S, Laitman Y, Azizi E, Molchadski I, Galore-Haskel G, Barak F, Cohen OS, Friedman E (2009) The leucine rich repeat kinase 2 (LRRK2) G2019S substitution mutation: association with Parkinson disease, malignant melanoma and prevalence in ethnic groups in Israel. J Neurol 256:483–487CrossRefPubMed

Hertel S, Sprenger A, Klein C, Kompf D, Helmchen C, Kimmig H (2009) Different saccadic abnormalities in PINK1 mutation carriers and in patients with non-genetic Parkinson’s disease. J Neurol 256:1192–1194CrossRefPubMed

Larisch A, Oertel WH, Eggert K (2009) Attitudes and barriers to clinical practice guidelines in general and to the guideline on Parkinson’s disease: a national survey of German neurologists in private practice. J Neurol 256:1681–1688CrossRefPubMed

Linder J, Birgander R, Olsson I, Riklund K, Larsson AK, Edstrom M, Stenlund H, Forsgren L (2009) Degenerative changes were common in brain magnetic resonance imaging in patients with newly diagnosed Parkinson’s disease in a population-based cohort. J Neurol 256:1671–1680CrossRefPubMed

Weiss PH, Dafotakis M, Metten L, Noth J (2009) Distal and proximal prehension is differentially affected by Parkinson’s disease: the effect of conscious and subconscious load cues. J Neurol 256:450–456CrossRefPubMed

Michel J, Benninger D, Dietz V, van Hedel HJA (2009) Obstacle stepping in patients with Parkinson’s disease: complexity does influence performance. J Neurol 256:457–463CrossRefPubMed

Mak MKY, Pang MYC (2009) Balance confidence and functional mobility are independently associated with falls in people with Parkinson’s disease. J Neurol 256:742–749CrossRefPubMed

10.

Mak MKY, Pang MYC (2009) Fear of falling is independently associated with recurrent falls in patients with Parkinson’s disease: a 1-year prospective study. J Neurol 256:1689–1695CrossRefPubMed

11.

Gago MF, Garrett MC, Fonseca MR, Rosas MJ, Simeos MF, Viera S, Botelho F (2009) How do cognitive and axial motor signs correlate in Parkinson’s disease? A 6-year prospective study. J Neurol 256:1655–1662CrossRefPubMed

12.

Santangelo G, Vitale C, Trojano L, Longo K, Cozzolino A, Grossi D, Barone P (2009) Relationship between depression and cognitive dysfunctions in Parkinson’s disease without dementia. J Neurol 256:632–638CrossRefPubMed

13.

Palhagen SE, Ekberg S, Walinder J, Granerus AK, Granerus G (2009) HMPAO SPECT in Parkinson’s disease (PD) with major depression (MD) before and after antidepressant treatment. J Neurol 256:1510–1518CrossRefPubMed

14.

Perez-Lloret S, Rossi M, Nouzeilles MI, Trenkwalkder C, Cardinali DP, Mercello M (2009) Parkinson’s disease sleep scale, sleep logs, and actinography in the evaluation of sleep in parkinsonian patients. J Neurol 256:1480–1484CrossRefPubMed

15.

Pinkhardt EH, Kassubek J, Sussmuth S, Ludolph AC, Becker W, Jurgens R (2009) Comparison of smooth pursuit eye movement deficits in multiple system atrophy and Parkinson’s disease. J Neurol 256:1438–1446CrossRefPubMed

16.

Kulisevsky J, Pagonabarraga J, Corral-Martinez M (2009) Changes in artistic style and behaviour in Parkinson’s disease: dopamine and creativity. J Neurol 256:816–819CrossRefPubMed

17.

Wolz M, Kaminsky A, Lohle M, Koch R, Storch A, Reichmann H (2009) Chocolate consumption is increased in Parkinson’s disease: results from a self-questionnaire study. J Neurol 256:488–492CrossRefPubMed

18.

Stewart KC, Fernandez HH, Okun MS, Alberts JL, Malaty IA, Rodriguez RL, Hass CJ (2009) Effects of dopaminergic medication on objective tasks of deftness, bradykinesia and force control. J Neurol 256:2030–2035CrossRef

19.

Tanaka Y, Kato T, Nishida H, Araki H, Murase M, Nagaki M, Moriwaki H, Inuzuka T (2009) Is there a difference in gastric emptying between Parkinson’s disease patients under long-term L-dopa therapy with and without motor fluctuations? An analysis using the 13C-acetate breath test. J Neurol 256:1972–1976CrossRef

20.

Lagalla G, Millevolte M, Capecci M, Provinciali L, Ceravolo MG (2009) Long-lasting benefits of botulinum toxin type B in Parkinson’s disease-related drooling. J Neurol 256:563–567CrossRefPubMed

21.

Simonin C, Tir M, Devos D, Kreisler A, Dukardin K, Salleron J, Delval A, Blond S, Defebvre L, Destee A, Krystkowiak P (2009) Reduced levodopa-induced complications after 5 years of subthalamic stimulation in Parkinson’s disease: a second honeymoon. J Neurol 256:1736–1741CrossRefPubMed

22.

Gervais-Bernard H, Xie-Brustolin J, Mertens P, Polo G, Klinger H, Adamec D, Broussolle E, Thobois S (2009) Bilateral subthalamic nucleus stimulation in advanced Parkinson’s disease: five year follow-up. J Neurol 256:225–233CrossRefPubMed

23.

Moro E, Allert N, Eleopra R, Houeto JL, Phan TM, Stoevelaar H, for the International Study Group on Referral Criteria for DBS (2009) A decision tool to support appropriate referral for deep brain stimulation in Parkinson’s disease. J Neurol 256:83–88CrossRefPubMed

24.

Guimaraes J, Matos E, Rosas MJ, Viera-Coelho A, Borges N, Correia F, Vaz R, Garrett C (2009) Modulation of nutritional state in Parkinsonian patients with bilateral subthalamic nucleus stimulation. J Neurol 256:2072–2078CrossRef

25.

Mercello M, Cavanagh S, Perez-Lloret RoldanE, Bruno V, Tenca E, Leiguarda R (2009) Irritability, psychomotor agitation and progressive insomnia induced by bilateral stimulation of the area surrounding the dorsal subthalamic nucleus (zona incerta) in Parkinson’s disease patients. J Neurol 256:2091–2093CrossRef

Title: Parkinson’s disease and 2009: recent advances
Authors: David P. Breen
Roger A. Barker
Publication date: 01-07-2010
Publisher: Springer-Verlag
Published in: Journal of Neurology / Issue 7/2010
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI: https://doi.org/10.1007/s00415-010-5555-y

At a glance: The STEP trials

Springer Medicine

Parkinson’s disease and 2009: recent advances

Abstract

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 7/2010

Falls and the falls efficacy scale in Parkinson’s disease

Early development of spasticity following stroke: a prospective, observational trial

Progressive anterior operculum syndrome due to FTLD-TDP: a clinico-pathological investigation

Absence of aquaporin-4 antibodies in patients with idiopathic intracranial hypertension

Requests for euthanasia: origin of suffering in ALS, heart failure, and cancer patients

Flexion contractures possibly reflect the existence of hypocortisolism: two case reports